The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | S | Sensory organs | |
| 2 | S01 | Ophthalmologicals | |
| 3 | S01A | Antiinfectives | |
| 4 | S01AA | Antibiotics | |
| 5 | S01AA12 | Tobramycin |
| Active Ingredient | Description | |
|---|---|---|
| Tobramycin |
Tobramycin is an aminoglycoside antibiotic produced by Streptomyces tenebrarius. It acts primarily by disrupting protein synthesis leading to altered cell membrane permeability, progressive disruption of the cell envelope and eventual cell death. It is bactericidal at concentrations equal to or slightly greater than inhibitory concentrations. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| TOBRABACT Eye drops, solution | Web Search | MPI, EU: SmPC | |
| TOBREX 0.3% Ophthalmic ointment | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| TOBREX 0.3% Ophthalmic solution | FDA, National Drug Code (US) | MPI, US: SPL/Old |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
